T Cell News and Research

Latest T Cell News and Research

Researchers deliver knock-out blow to different types of cancer

Targeting healthy cells that have been hijacked by cancer cells could help treat many different types of the disease, according to research funded by Cancer Research UK and published in the Journal of the National Cancer Institute today (Thursday).

3 Aug 2017

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.

2 Aug 2017

Researchers ferreting out patients most likely to become resistant to cancer treatment

According to the National Cancer Institute, the number of people beating a cancer diagnosis reached nearly 14.5 million in 2014 and is expected to rise to almost 19 million by 2024. Now, that's good news, but it doesn't mean that cancer researchers - in the lab or clinic - are resting on any laurels.

2 Aug 2017

Anti-allergy medicines may be effective treatment for deadly blood clots in the legs

Common anti-allergy medicines could prove to be an effective treatment for potentially fatal blood clots in the legs, according to new research by the University of Birmingham.

2 Aug 2017

Scientists reveal new method to reprogram specific T cells

When the immune system is imbalanced, either due to overly-active cells or cells that suppress its function, it causes a wide range of diseases, from psoriasis to cancer.

2 Aug 2017

Stowers researchers solve 3D structure of critical protein complex using microscopy techniques

Researchers at the Stowers Institute for Medical Research have solved the three-dimensional structure of a complex that is essential for the correct sorting of chromosomes into eggs and sperm during reproductive cell division or meiosis.

2 Aug 2017

Research shows great potential of embryonic gene editing to prevent inherited diseases

Scientists have, for the first time, corrected a disease-causing mutation in early stage human embryos with gene editing.

2 Aug 2017

Vanderbilt researchers unravel how bacterial toxin prevents DNA replication

One of the most potent toxins known acts by welding the two strands of the famous double helix together in a unique fashion which foils the standard repair mechanisms cells use to protect their DNA.

2 Aug 2017

UC sociologists explore how condemned prisoners get dressed for death

What would you wear to your own execution? It's a moot question in the United States now as most death row prisoners wear prison garb. But for more than two centuries, the choice was up to the condemned.

2 Aug 2017

Kinase-inactive BRAF mutation triggers lung adenocarcinoma development

The initiating oncogenic event in almost half of human lung adenocarcinomas is still unknown, a fact that complicates the development of selective targeted therapies.

2 Aug 2017

TUM scientists provide new insights into development of T cells

When T cells encounter an antigen, they proliferate and produce various types of daughter cells. A team at the Technical University of Munich has now refuted the prevailing hypothesis that this immune response is largely predetermined by the individual structure of the T cell receptor.

2 Aug 2017

Shaping the future of oncology treatment

Victories Over Cancer is about enabling those affected by cancer to enjoy more of life’s meaning full moments and making cancer more manageable. At Janssen, we're really thinking about the elimination of cancer, and we take a very deliberate approach to that.

2 Aug 2017

Natera's Panorama™ NIPT now offered by Biopticka Laborator in Czech Republic

Natera (NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, and Biopticka Laborator, one of the largest and most well-established laboratories in the Czech Republic, today announced a Constellation™ technology transfer licensing agreement that enables Biopticka Laborator to leverage Natera’s proprietary single nucleotide polymorphism-based (SNP) technology to screen for fetal aneuploidies.

From Natera 2 Aug 2017

$New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod$

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

The U.S. Food and Drug Administration (FDA) in a statement yesterday reported its approval for a new drug, Idhifa (enasidenib) for the treatment of acute myeloid leukemia (AML) in adults that has either relapsed or is refractory to standard chemotherapy.

2 Aug 2017

Latency reversing agent makes dormant HIV-infected cells vulnerable to clearance

The ability for HIV to hide in the body in a dormant state makes curing the 40 million people living with the virus a challenge. Researchers at the University of North Carolina at Chapel Hill have shown the drug Vorinostat reverses this latency, causing resting CD4 T-cells to express HIV.

1 Aug 2017

Salk scientist Reuben Shaw wins NCI Outstanding Investigator Award

Salk Professor Reuben Shaw has received the National Cancer Institute Outstanding Investigator Award (OIA), which encourages cancer research with breakthrough potential. Shaw, a member of Salk's Molecular and Cell Biology Laboratory and holder of the William R. Brody Chair, will receive $4.2 million in direct funding over the next seven years to further his work.

1 Aug 2017

Expert highlights CRISPR’s applications, limitations, and ethical concerns

"Good morning, doctor, I am here for my gene editing appointment." In the future, could this be a greeting heard in physician offices around the world? With the introduction of CRISPR technology, genetic material can now be more easily and precisely edited, even creating changes that can subsequently be inherited by offspring.

1 Aug 2017

"Fat switch" may hold the key to obesity finds new study

Scientists have been trying for years now to understand what causes overweight and obesity in some but not in others. Now researchers at the Monash University's Biomedicine Discovery Institute seem to have solved the puzzle that has been baffling them all – a so called “fat switch” in the brain that regulates weight gain. This could also mean a new potential for treatment of obesity in future. The study appeared in the journal Cell Metabolism today.

1 Aug 2017

Scientists receive NSF grant to develop new methods for decoding neural data

Research and new technologies have dramatically expanded the amount of data that can be captured from the brain over the past few years. The challenge now is to determine what that data can tell us.

1 Aug 2017

Consumption of artificial sweeteners alongside low carbohydrate diet increases food intake

Next time you drop an artificial sweetener into your coffee thinking of the weight you'll lose by avoiding sugar, think again.

1 Aug 2017

T Cell News and Research

Latest T Cell News and Research

Researchers deliver knock-out blow to different types of cancer

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Researchers ferreting out patients most likely to become resistant to cancer treatment

Anti-allergy medicines may be effective treatment for deadly blood clots in the legs

Scientists reveal new method to reprogram specific T cells

Stowers researchers solve 3D structure of critical protein complex using microscopy techniques

Research shows great potential of embryonic gene editing to prevent inherited diseases

Vanderbilt researchers unravel how bacterial toxin prevents DNA replication

UC sociologists explore how condemned prisoners get dressed for death

Kinase-inactive BRAF mutation triggers lung adenocarcinoma development

TUM scientists provide new insights into development of T cells

Shaping the future of oncology treatment

Natera's Panorama™ NIPT now offered by Biopticka Laborator in Czech Republic

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

Latency reversing agent makes dormant HIV-infected cells vulnerable to clearance

Salk scientist Reuben Shaw wins NCI Outstanding Investigator Award

Expert highlights CRISPR’s applications, limitations, and ethical concerns

"Fat switch" may hold the key to obesity finds new study

Scientists receive NSF grant to develop new methods for decoding neural data

Consumption of artificial sweeteners alongside low carbohydrate diet increases food intake

Immunology eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in